Literature DB >> 32146612

What is the risk of venous cerebellar infarction in the supracerebellar infratentorial approach?

Martin Smrcka1,2, Ondrej Navratil3,4.   

Abstract

The supracerebellar infratentorial approach (SCITA) is a standard approach used in a neurosurgical practice. It carries some risk of associated complications including cerebellar venous infarction with possible serious sequelae. The objective of this study is to address the incidence of cerebellar venous infarction in SCITA. A search through the currently available literature was performed in September 2019 from the year 2000 until September 2019 dealing with 'supracerebellar infratentorial approach'. Out of the 578 patients found in thirteen case series, two venous infarctions were present; the remaining four patients were published as case reports. By analysing the case series, we calculated the risk of such a complication to be 0.345% (95% CI [0.061%, 1.248%]). Case reports were not included. The real risk is estimated to be higher. The risk of cerebellar venous infarction is an unpredictable, infrequent but real complication with potentially dreadful sequelae. Each neurosurgeon using this approach should be aware of this event when employing this approach. The avoidance of cerebellar venous infarction can be lowered by leaving as many bridging veins intact as possible.

Entities:  

Keywords:  Bridging vein; Complication; Supracerebellar infratentorial approach; Venous infarction

Year:  2020        PMID: 32146612     DOI: 10.1007/s10143-020-01269-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  9 in total

1.  Supracerebellar infratentorial approach with paramedian expansion for posterior third ventricular and pineal region lesions.

Authors:  Hisham Aboul-Enein; Ahmed Abd El-Aziz Sabry; Ahmed Hafez Farhoud
Journal:  Clin Neurol Neurosurg       Date:  2015-09-25       Impact factor: 1.876

2.  Surgical Approach to Ponto-mesencephalic Cavernoma.

Authors:  Yasuhiko Kaku; Hiroaki Takei; Masafumi Miyai; Kentarou Yamashita; Jouji Kokuzawa
Journal:  Acta Neurochir Suppl       Date:  2016

Review 3.  Is surgery for pineal cysts safe and effective? Short review.

Authors:  Martin Májovský; David Netuka; Vladimír Beneš
Journal:  Neurosurg Rev       Date:  2017-07-12       Impact factor: 3.042

4.  Large epidermoids of the quadrigeminal cistern: an experience of 15 consecutive cases and review of literature.

Authors:  Prakash Nair; Rabi Narayan Sahu; R Kumar; S Behari; Anup P Nair; A K Srivastava
Journal:  Acta Neurochir (Wien)       Date:  2012-06-27       Impact factor: 2.216

5.  Supracerebellar infratentorial approach for pineal region tumors: Our surgical and technical considerations.

Authors:  C Mottolese; A Szathmari; A C Ricci-Franchi; P Gallo; P A Beuriat; G Capone
Journal:  Neurochirurgie       Date:  2014-05-24       Impact factor: 1.553

6.  Neurosurgical venous considerations for tumors of the pineal region resected using the infratentorial supracerebellar approach.

Authors:  Toshiaki Kodera; Oliver Bozinov; Oguzkan Sürücü; Nils H Ulrich; Jan-Karl Burkhardt; Helmut Bertalanffy
Journal:  J Clin Neurosci       Date:  2011-09-13       Impact factor: 1.961

7.  Operative results of keyhole supracerebellar-infratentorial approach to the pineal region.

Authors:  Phillip A Bonney; Lillian B Boettcher; Ahmed A Cheema; Adrian J Maurer; Michael E Sughrue
Journal:  J Clin Neurosci       Date:  2015-04-22       Impact factor: 1.961

8.  Microsurgical management of pineal region lesions: personal experience with 119 patients.

Authors:  Juha Hernesniemi; Rossana Romani; Baki S Albayrak; Hanna Lehto; Reza Dashti; Christian Ramsey; Ayse Karatas; Andrea Cardia; Ondrej Navratil; Anna Piippo; Minoru Fujiki; Stefano Toninelli; Mika Niemelä
Journal:  Surg Neurol       Date:  2008-12

9.  Clinical and neurophysiological changes in patients with pineal region expansions.

Authors:  Sanja Hajnsek; Josip Paladino; Zeljka Petelin Gadze; Sibila Nanković; Goran Mrak; Velimir Lupret
Journal:  Coll Antropol       Date:  2013-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.